EMG
ETF Managers Group Portfolio holdings
AUM
$3.1B
1-Year Return
17.12%
This Quarter Return
-2.01%
1 Year Return
-17.12%
3 Year Return
+78.5%
5 Year Return
+64.08%
10 Year Return
–
AUM
$5.05B
AUM Growth
-$270M
(-5.1%)
Cap. Flow
-$89.3M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
17.38%
Holding
782
New
109
Increased
317
Reduced
269
Closed
85
Top Buys
| 1 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
$49.1M |
| 2 |
FORG
ForgeRock, Inc.
FORG
|
$47.9M |
| 3 |
MAG
MAG Silver
MAG
|
$23.3M |
| 4 |
iShares MSCI South Korea ETF
EWY
|
$19.8M |
| 5 |
Jack Henry & Associates
JKHY
|
$18.4M |
Top Sells
| 1 |
VGR
Vector Group Ltd.
VGR
|
$26.3M |
| 2 |
Cloudflare
NET
|
$19.7M |
| 3 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$17M |
| 4 |
ZIXI
Zix Corporation
ZIXI
|
$16.4M |
| 5 |
OGI
Organigram Holdings
OGI
|
$15.9M |
Sector Composition
| 1 | Technology | 50.31% |
| 2 | Materials | 12.82% |
| 3 | Healthcare | 9.84% |
| 4 | Financials | 7.06% |
| 5 | Industrials | 4.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDAK
651
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $74K | ﹤0.01% |
6,761
-1,007
| -13% | -$11K |
|
652
ARS Pharmaceuticals
SPRY
$995M
| $70K | ﹤0.01% |
10,605
-1,204
| -10% | -$7.95K |
|
653
Angi Inc
ANGI
$811M
| $68K | ﹤0.01% |
+734
| New | +$68K |
|
|
PRTK
654
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $68K | ﹤0.01% |
15,173
-2,000
| -12% | -$8.96K |
|
|
MTTR
655
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $66K | ﹤0.01% |
+3,022
| New | +$66K |
|
|
ABTC
656
American Bitcoin Corp. Class A Common Stock
ABTC
$613M
| $65K | ﹤0.01% |
18
+15
| +500% | +$54.2K |
|
657
Atossa Therapeutics
ATOS
$102M
| $64K | ﹤0.01% |
+38,452
| New | +$64K |
|
|
RDFN
658
DELISTED
Redfin
RDFN
| $62K | ﹤0.01% |
+1,578
| New | +$62K |
|
|
ATHX
659
DELISTED
Athersys, Inc. Common Stock
ATHX
| $62K | ﹤0.01% |
2,845
-292
| -9% | -$6.36K |
|
660
Paysign
PAYS
$286M
| $61K | ﹤0.01% |
36,052
-600,204
| -94% | -$1.02M |
|
661
InflaRx
IFRX
$112M
| $59K | ﹤0.01% |
13,354
-2,780
| -17% | -$12.3K |
|
|
TCN
662
DELISTED
Tricon Residential Inc.
TCN
| $59K | ﹤0.01% |
+3,905
| New | +$59K |
|
663
Radian Group
RDN
$4.79B
| $57K | ﹤0.01% |
+2,683
| New | +$57K |
|
664
Compass
COMP
$5.07B
| $56K | ﹤0.01% |
+6,088
| New | +$56K |
|
665
CorMedix
CRMD
$926M
| $54K | ﹤0.01% |
11,510
-2,660
| -19% | -$12.5K |
|
666
Immunome
IMNM
$916M
| $51K | ﹤0.01% |
3,658
-542
| -13% | -$7.56K |
|
667
Inseego
INSG
$199M
| $50K | ﹤0.01% |
860
-89
| -9% | -$5.17K |
|
668
Tonix Pharmaceuticals
TNXP
$233M
| – | – |
0
| – | -$72K |
|
|
ENZ
669
DELISTED
Enzo Biochem, Inc.
ENZ
| $47K | ﹤0.01% |
14,651
-2,625
| -15% | -$8.42K |
|
670
Backblaze
BLZE
$491M
| $42K | ﹤0.01% |
+2,420
| New | +$42K |
|
|
EGIO
671
DELISTED
Edgio, Inc. Common Stock
EGIO
| $39K | ﹤0.01% |
279
-16
| -5% | -$2.24K |
|
672
iBio
IBIO
$16.4M
| $38K | ﹤0.01% |
132
-21
| -14% | -$6.05K |
|
|
PHAS
673
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $38K | ﹤0.01% |
14,536
-2,636
| -15% | -$6.89K |
|
|
XNET
674
Xunlei
XNET
$479M
| $34K | ﹤0.01% |
16,653
-73
| -0.4% | -$149 |
|
675
Assembly Biosciences
ASMB
$183M
| $33K | ﹤0.01% |
1,206
-162
| -12% | -$4.43K |
|